Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Notch Signaling in Acute Myeloid Leukemia (AML)

Paul Takam Kamga, BSc, MSc, Federica Resci, MD, Giada Dal Collo, MSc, Annalisa Adamo, MSc, Riccardo Bazzoni, MSc, Angela Mercuri, MSc, Massimiliano Bonifacio, Mauro Krampera, MD PhD

Blood (2018) 132 (Supplement 1): 5242.

https://doi.org/10.1182/blood-2018-99-118701

Published: 2018

Journal Articles

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS?

Blood (2018) 132 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2018-99-115971

Published: 2018

Journal Articles

The Prognostic Impact of t(14;20) in Multiple Myeloma - a Multicenter Retrospective Study of 26 Patients

Artur Jurczyszyn, MD, Sarah Goldman-Mazur, MD, Jorge J. Castillo, MD, Anna Waszczuk-Gajda, Norbert Grząśko, MD PhD, Max Bittrich, MD, Andrew J Yee, MD, Anna Suska, MD, Deepu Madduri, MD, Saurabh Chhabra, MD, Ariel Kleman, MD, Parameswaran Hari, MBBS, MD, Stuart L. Goldberg, MD, Aimee Chappell, Massimo Gentile, David H. Vesole, MD PhD

Blood (2018) 132 (Supplement 1): 5600.

https://doi.org/10.1182/blood-2018-99-115816

Published: 2018

Journal Articles

Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis

Blood (2016) 128 (22): 1677.

https://doi.org/10.1182/blood.V128.22.1677.1677

Published: 2016

Journal Articles

Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma

Namratha R Vontela, MD, Kenneth Byrd, Brennan McCullar, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 5399.

https://doi.org/10.1182/blood.V128.22.5399.5399

Published: 2016

Journal Articles

Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience

Aditya Deshpande, Maria Monica Gramatges, MD PhD, Ghadir S. Sasa, MD, Philip J Lupo, PhD MPH, Rachel E Rau, MD, Michele S. Redell, MD PhD, Terzah M. Horton, MD PhD, Michael E Scheurer, PhD MPH, Karen R. Rabin, MD PhD

Blood (2015) 126 (23): 1312.

https://doi.org/10.1182/blood.V126.23.1312.1312

Published: 2015

Journal Articles

EUTOS Score Predicts Long-Term Outcome in Chronic Myeloid Leukemia Patients Transitioning from Pre-Imatinib Era to Imatinib upon Availability

Pratik Deb, MBBS, Uttam Nath, M.B.B.S., MD, D.M., Rajarshi Aich, M.B.B.S, Siddhartha Sankar Ray, M.B.B.S., MD, D.M., Prantar Chakrabarti, MBBS,MDDM

Blood (2015) 126 (23): 4023.

https://doi.org/10.1182/blood.V126.23.4023.4023

Published: 2015

Journal Articles

The Role of Tumor Associated Macrophages in Multiple Myeloma and Its Pathophysiological Effect on Myeloma Cells Survival, Apopotosis and Angiogenesis

Yu Wu, MD PhD, Xinyi Chen, Yuhuan Zheng

Blood (2015) 126 (23): 4204.

https://doi.org/10.1182/blood.V126.23.4204.4204

Published: 2015

Journal Articles

Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden

Brooke Snetsinger, MSc, Emily Heath, BSc, Michael J. Rauh, MD PhD

Blood (2015) 126 (23): 1668.

https://doi.org/10.1182/blood.V126.23.1668.1668

Published: 2015

Journal Articles

Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B Cell Acute Lymphoblastic Leukemia

Sakiko Yoshida, MDPhD, Emily Tuscano, Connie Duong, BS, Joseph Tuscano, MD, Noriko Satake, MD

Blood (2014) 124 (21): 971.

https://doi.org/10.1182/blood.V124.21.971.971

Published: 2014

Journal Articles

The SMAC Mimetic Lcl-161 Augments the in Vitro and in Vivo anti-Tumor Activity of Rituximab and Chemotherapy in Rituximab Relapse/Refractory Lymphoma Models

Kyle L. Runckel, BS, Joseph Skitzki, MD, Francisco Hernandez, MD, Myron S. Czuczman, MD

Blood (2014) 124 (21): 3110.

https://doi.org/10.1182/blood.V124.21.3110.3110

Published: 2014

Journal Articles

Secondary CNS Relapse in DLBCL in the Rituximab Era - an Analysis of Prospective Studies

Abhimanyu Ghose, MD, Harold Kunal Elias, MD, Gunjan Guha, MSc, PhD, Mahender Yellu, MD, Ria Kundu, MD, Tahir Latif, MD

Blood (2014) 124 (21): 1644.

https://doi.org/10.1182/blood.V124.21.1644.1644

Published: 2014

Journal Articles

Weekly Subcutaneous Bortezomib Is Well Tolerated and Effective As Initial Therapy Of Symptomatic Myeloma

David Simpson, MBChB, FRACP, FRCPA, Rory McCulloch, MBChB, James Liang, MBChB, Sarah Mant, Naomi Whyler, Liam J. Fernyhough, MB, BS,, BMedSci

Blood (2013) 122 (21): 3229.

https://doi.org/10.1182/blood.V122.21.3229.3229

Published: 2013

Journal Articles

Impact Of Dialysis-Dependent Renal Failure At Time Of Myeloma Diagnosis On Overall Survival - a 15-Year Single Centre Analysis

Philip T Murphy, MD, MRCPath, Cherisse Baldeo, MB, Patrick O'Kelly, Jeremy Sargant, MB, Patrick Thornton, MB, Mary McCloy, MB, MRCP, MRCPath, Peter Conlon, MB, Colm Magee, MB, Mark Denton, MB, John Quinn, MB, PhD

Blood (2013) 122 (21): 3230.

https://doi.org/10.1182/blood.V122.21.3230.3230

Published: 2013

Journal Articles

Recombinant Human Thrombopoietin and Rituximab vs Rituximab Monotherapy in Corticosteroid-Resistant Primary Immune Thrombocytopenia: a Multicenter Randomized Controlled Study

Miao Xu, Ping Qin, Xiaoyuan Dong, Jie Li, Haiyan Zhang, Xin Wang, Yuesheng Meng, Chenglu Yuan, Hongguo Zhao, Jun Peng, Ming Hou

Blood (2013) 122 (21): 329.

https://doi.org/10.1182/blood.V122.21.329.329

Published: 2013

Journal Articles

Prior Treatment with Chemotherapy Is Associated with Poor Outcomes of High Risk Skin Cancers in Patients with Chronic Lymphocytic Leukemia

Matthew S. Davids, MD, Nicole F. Velez, MD, Pritesh Karia, MPH, Ye Guo, MSCS, Alexander R. Vartanov, BS, Victor A. Neel, MD, PhD, Jennifer R. Brown, MD, PhD, Chrysalyne D. Schmults, MD, MSCE

Blood (2012) 120 (21): 3920.

https://doi.org/10.1182/blood.V120.21.3920.3920

Published: 2012

Journal Articles

Heritability of Hematologic Neoplasms in Twins: An Update

Ali Ozhand, M.D., Thomas M. Mack, M.D., M.P.H., Sophia S. Wang, PhD, Ann S. Hamilton, Ph.D., Amie E. Hwang, Ph.D., M.P.H., Dennis K. Deapen, Dr.PH., Bharat N. Nathwani, M.D., Wendy Cozen, D.O., M.P.H.

Blood (2012) 120 (21): 3636.

https://doi.org/10.1182/blood.V120.21.3636.3636

Published: 2012

Journal Articles

Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes

Mari F. C. M. van den Hout, Bas D. Koster, Berbel J. R. Sluijter, Paul A. M. van Leeuwen, Sybren Meijer, Monique Petrousjka van den Tol, Alfons J. M. van den Eertwegh, Rik J. Scheper, Rieneke van de Ven, Tanja D. de Gruijl

Blood (2012) 119 (20): 4809–4810.

https://doi.org/10.1182/blood-2012-03-413294

Published: 2012

Journal Articles

Pretreatment Expression Levels of MDR1 and OCT-1 Predict Response to First Line Imatinib Treatment In Chronic Phase CML Patients

Blood (2010) 116 (21): 671.

https://doi.org/10.1182/blood.V116.21.671.671

Published: 2010

Journal Articles

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis.

Sergio Siragusa, MD, Alessandra Malato, MD, Fabio Fulfaro, Giorgia Saccullo, Domenica Caramazza, Giusy Pizzo, Lucio lo Coco, Nicola Gebbia

Blood (2009) 114 (22): 3999.

https://doi.org/10.1182/blood.V114.22.3999.3999

Published: 2009

NARROW

Prognostic Impact of Notch Signaling in Acute Myeloid Leukemia (AML)

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS?

The Prognostic Impact of t(14;20) in Multiple Myeloma - a Multicenter Retrospective Study of 26 Patients

Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis

Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma

Poorer Relapse-Free Survival in Hispanic Children Diagnosed with Acute Myeloid Leukemia Compared with Non-Hispanics: A Texas Single Institution Experience

EUTOS Score Predicts Long-Term Outcome in Chronic Myeloid Leukemia Patients Transitioning from Pre-Imatinib Era to Imatinib upon Availability

The Role of Tumor Associated Macrophages in Multiple Myeloma and Its Pathophysiological Effect on Myeloma Cells Survival, Apopotosis and Angiogenesis

Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden

Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B Cell Acute Lymphoblastic Leukemia

The SMAC Mimetic Lcl-161 Augments the in Vitro and in Vivo anti-Tumor Activity of Rituximab and Chemotherapy in Rituximab Relapse/Refractory Lymphoma Models

Secondary CNS Relapse in DLBCL in the Rituximab Era - an Analysis of Prospective Studies

Weekly Subcutaneous Bortezomib Is Well Tolerated and Effective As Initial Therapy Of Symptomatic Myeloma

Impact Of Dialysis-Dependent Renal Failure At Time Of Myeloma Diagnosis On Overall Survival - a 15-Year Single Centre Analysis

Recombinant Human Thrombopoietin and Rituximab vs Rituximab Monotherapy in Corticosteroid-Resistant Primary Immune Thrombocytopenia: a Multicenter Randomized Controlled Study

Prior Treatment with Chemotherapy Is Associated with Poor Outcomes of High Risk Skin Cancers in Patients with Chronic Lymphocytic Leukemia

Heritability of Hematologic Neoplasms in Twins: An Update

Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes

Pretreatment Expression Levels of MDR1 and OCT-1 Predict Response to First Line Imatinib Treatment In Chronic Phase CML Patients

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only